Literature DB >> 22312073

Incidence and risk factors of the post-thrombotic syndrome.

M A F de Wolf1, C H A Wittens, S R Kahn.   

Abstract

Annually 1-2 in every 1000 adults will develop a deep venous thrombosis of the lower extremity. A third to half of these patients will develop the post-thrombotic syndrome (PTS). However, predicting which patients will develop the PTS remains elusive. Ipsilateral thrombosis recurrence seems to be the most important risk factor. Moreover, residual venous occlusion and valvular reflux seem to predict PTS incidence to some degree. Laboratory parameters, including d-dimers and inflammatory markers, have shown promise in predicting development of the PTS in patients and are currently under investigation. Creating a model based on all combined risk factors and patient characteristics might aid in risk stratification in individual patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22312073     DOI: 10.1258/phleb.2011.012s06

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  3 in total

Review 1.  Antiplatelet agents for the treatment of deep venous thrombosis.

Authors:  Carolina Dq Flumignan; Luis Cu Nakano; Jose Cc Baptista-Silva; Ronald Lg Flumignan
Journal:  Cochrane Database Syst Rev       Date:  2022-07-25

Review 2.  Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.

Authors:  Kang-Ling Wang; Pao-Hsien Chu; Cheng-Han Lee; Pei-Ying Pai; Pao-Yen Lin; Kou-Gi Shyu; Wei-Tien Chang; Kuan-Ming Chiu; Chien-Lung Huang; Chung-Yi Lee; Yen-Hung Lin; Chun-Chieh Wang; Hsueh-Wei Yen; Wei-Hsian Yin; Hung-I Yeh; Chern-En Chiang; Shing-Jong Lin; San-Jou Yeh
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

3.  Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome?

Authors:  Stefano de Franciscis; Luca Gallelli; Bruno Amato; Lucia Butrico; Alessio Rossi; Gianluca Buffone; Francesco G Caliò; Giovanni De Caridi; Raffaele Grande; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.